"FDA" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonUS FDA finds radioactive contamination in spices after shrimp recall - Times of India
US FDA finds radioactive contamination in spices after shrimp recall Times of India
After Radioactive Shrimp Recall, FDA Detects More Cs-137 in Indonesian Spice Import - Food Safety...
After Radioactive Shrimp Recall, FDA Detects More Cs-137 in Indonesian Spice Import Food Safety Magazine
FDA warns of possible radioactive shrimp risk again in new 31-state recall - Axios
FDA warns of possible radioactive shrimp risk again in new 31-state recall Axios
What is leucovorin, the drug the FDA approved to treat autism? - The Guardian
What is leucovorin, the drug the FDA approved to treat autism? The Guardian
What Vertex Pharmaceuticals (VRTX)'s FDA Breakthrough for Povetacicept Means for Kidney Disease P...
What Vertex Pharmaceuticals (VRTX)'s FDA Breakthrough for Povetacicept Means for Kidney Disease Pipeline Yahoo Finance
FDA authorizes first eyeglass lenses to slow nearsightedness in children in the US - CNN
FDA authorizes first eyeglass lenses to slow nearsightedness in children in the US CNN
RFK Jr. launches FDA review of abortion pill - ABC News - Breaking News, Latest News and Videos
RFK Jr. launches FDA review of abortion pill ABC News - Breaking News, Latest News and Videos
Kennedy says FDA is reviewing safety of abortion pill mifepristone - CBS News
Kennedy says FDA is reviewing safety of abortion pill mifepristone CBS News
RFK Jr. says FDA will "study" new safety limits on abortion pill - Axios
RFK Jr. says FDA will "study" new safety limits on abortion pill Axios
U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or me...
U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer Eli Lilly and Company
Lilly’s Oral SERD Wins FDA Go-Ahead for Breast Cancer - BioSpace
Lilly’s Oral SERD Wins FDA Go-Ahead for Breast Cancer BioSpace
US FDA approves Eli Lilly's therapy for advanced breast cancer - Reuters
US FDA approves Eli Lilly's therapy for advanced breast cancer Reuters
Crinetics breaks the commercial barrier with FDA nod for oral acromegaly med Palsonify - Fierce P...
Crinetics breaks the commercial barrier with FDA nod for oral acromegaly med Palsonify Fierce Pharma
Crinetics wins FDA approval for acromegaly drug, faces competition with Novartis and Ipsen - stat...
Crinetics wins FDA approval for acromegaly drug, faces competition with Novartis and Ipsen statnews.com
FDA Approves Crinetics’ Once-Daily Acromegaly Treatment - BioSpace
FDA Approves Crinetics’ Once-Daily Acromegaly Treatment BioSpace
Trump goes beyond his own FDA with Tylenol warning - CNN
FDA Commissioner Dr. Marty Makary tells Scripps News 'I don't think autism is genetic' - Scripps ...
FDA Commissioner Dr. Marty Makary tells Scripps News 'I don't think autism is genetic' Scripps News
Does FDA's Leucovorin Decision Meet the Bar for Gold-Standard Science? - MedPage Today
Does FDA's Leucovorin Decision Meet the Bar for Gold-Standard Science? MedPage Today
Omaha experts weigh in as FDA approves at-home flu vaccine - WOWT
Omaha experts weigh in as FDA approves at-home flu vaccine WOWT
FDA clears its 1st eyeglasses for slowing childhood nearsightedness, from EssilorLuxottica - Fier...
FDA clears its 1st eyeglasses for slowing childhood nearsightedness, from EssilorLuxottica Fierce Biotech
Food Allergies - fda.gov
Food Allergies fda.gov
RFK Jr. launches FDA review of mifepristone. Is it safe to stock up on the abortion pill? - USA T...
RFK Jr. launches FDA review of mifepristone. Is it safe to stock up on the abortion pill? USA Today
FDA Fast Tracks GLSI-100 for HER2-Positive Breast Cancer Recurrence Prevention - Oncodaily
FDA Fast Tracks GLSI-100 for HER2-Positive Breast Cancer Recurrence Prevention Oncodaily
After massive shrimp recalls, the FDA finds radioactive contamination in spices too - AP News
After massive shrimp recalls, the FDA finds radioactive contamination in spices too AP News
F.D.A.’s Approval of a Drug for Autism Upends Review Process - The New York Times
F.D.A.’s Approval of a Drug for Autism Upends Review Process The New York Times
Paltusotine FDA Approved for Acromegaly in Adults | AJMC - The American Journal of Managed Care® ...
Paltusotine FDA Approved for Acromegaly in Adults | AJMC The American Journal of Managed Care® (AJMC®)
7 FDA Headlines You Missed in September 2025 - HCPLive
US FDA approves Crinetics' oral pill for rare hormone disorder - Reuters
US FDA approves Crinetics' oral pill for rare hormone disorder Reuters
Investigations of Foodborne Illness Outbreaks - fda.gov
Sunscreen: How to Help Protect Your Skin from the Sun - fda.gov
Sunscreen: How to Help Protect Your Skin from the Sun fda.gov
FDA Digital Health Advisory Committee - fda.gov
Aquastar (USA) Corp Recalls Kroger Frozen Raw EZ Peel, Kroger Mercado Frozen Cooked Shrimp, and A...
FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity - fda.gov
FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity fda.gov
Beyond the Headlines: FDA Warning Letters to GLP-1 Compounders - Spencer Fane
Beyond the Headlines: FDA Warning Letters to GLP-1 Compounders Spencer Fane
RFK Jr. sets off new abortion alarms with latest move - Axios
Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism - The Cancer L...
Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism The Cancer Letter
Color Additives - Information for Consumers - fda.gov
FDA Drops REMS Requirement for Vandetanib in Medullary Thyroid Cancer - CancerNetwork
FDA Drops REMS Requirement for Vandetanib in Medullary Thyroid Cancer CancerNetwork
FDA Approves Extended Indication for Evkeeza - Managed Healthcare Executive
FDA Approves Extended Indication for Evkeeza Managed Healthcare Executive
FDA Approves Inluriyo for ESR1-Mutated Advanced Breast Cancer Based on Phase III EMBER-3 Trial Da...
FDA Approves Inluriyo for ESR1-Mutated Advanced Breast Cancer Based on Phase III EMBER-3 Trial Data Applied Clinical Trials
FDA Approves Paltusotine (Palsonify) As First Once-Daily, Oral Acromegaly Treatment - HCPLive
FDA Approves Paltusotine (Palsonify) As First Once-Daily, Oral Acromegaly Treatment HCPLive
How the FDA’s crackdown on pharma ads may play out legally - Medical Marketing and Media
How the FDA’s crackdown on pharma ads may play out legally Medical Marketing and Media
Domino Recalls Sugar as FDA Issues Consumer Risk Warning - Newsweek
Domino Recalls Sugar as FDA Issues Consumer Risk Warning Newsweek
Federal agencies are studying safety of abortion drug mifepristone, driving new concerns about li...
FDA Approves Evinacumab (Evkeeza) for HoFH in Children As Young As 1 Year Old - HCPLive
FDA Approves Evinacumab (Evkeeza) for HoFH in Children As Young As 1 Year Old HCPLive
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH - The American Jou...
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH The American Journal of Managed Care® (AJMC®)
FDA’s Release of Complete Response Letters Raises Questions Related to Intellectual Property - Wi...
FDA’s Release of Complete Response Letters Raises Questions Related to Intellectual Property Wilson Sonsini
FDA Update: Agency Approves Evinacumab-dgnb ANGPTL3 Antibody For Children With HoFH - American Co...
FDA Update: Agency Approves Evinacumab-dgnb ANGPTL3 Antibody For Children With HoFH American College of Cardiology
With FDA Nod in Rare Hormone Disease, Crinetics Can Challenge Blockbuster Meds From Novartis, Ips...
With FDA Nod in Rare Hormone Disease, Crinetics Can Challenge Blockbuster Meds From Novartis, Ipsen MedCity News
FDA Approves Imlunestrant (Inluriyo) for ER+, HER2−, ESR1-Mutated Advanced Breast Cancer - Oncolo...
FDA Approves Imlunestrant (Inluriyo) for ER+, HER2−, ESR1-Mutated Advanced Breast Cancer Oncology News Central
Biolinq Shine Receives FDA De Novo Classification as First Multi-Analyte Wearable for Type 2 Diab...
Biolinq Shine Receives FDA De Novo Classification as First Multi-Analyte Wearable for Type 2 Diabetes Pharmacy Times
FDA authorizes marketing of Essilor Stellest eyeglass lenses for myopia - Eyes On Eyecare
FDA authorizes marketing of Essilor Stellest eyeglass lenses for myopia Eyes On Eyecare
FDA blocks more Indonesian shrimp as radioactive recall expands; U.S. shrimpers demand action - f...
FDA blocks more Indonesian shrimp as radioactive recall expands; U.S. shrimpers demand action fox8live.com
This Week at FDA: FDA’s autism moves, Novartis gets untitled letter over TV ad, and more - Regula...
This Week at FDA: FDA’s autism moves, Novartis gets untitled letter over TV ad, and more Regulatory Affairs Professionals Society | RAPS
FDA is conducting review of abortion drug mifepristone - NewsNation
FDA is conducting review of abortion drug mifepristone NewsNation
Tanja Obradovic: Real World Data and Evidence in FDA Regulatory Decisions - Oncodaily
Tanja Obradovic: Real World Data and Evidence in FDA Regulatory Decisions Oncodaily
Paltusotine Receives FDA Approval to Treat Acromegaly in Adults - Pharmacy Times
Paltusotine Receives FDA Approval to Treat Acromegaly in Adults Pharmacy Times
FDA official: Clinical, CMC teams should be on the same page when developing CGTs - Regulatory Af...
FDA official: Clinical, CMC teams should be on the same page when developing CGTs Regulatory Affairs Professionals Society | RAPS
FDA Green Lights Ruthlessly Practical ‘Smart’ Device - Orthopedics This Week
FDA Green Lights Ruthlessly Practical ‘Smart’ Device Orthopedics This Week
Cigarette Labeling and Health Warning Requirements - fda.gov
Palsonify, an Oral Therapy for Acromegaly, Gets FDA Approval - Medical Professionals Reference
Palsonify, an Oral Therapy for Acromegaly, Gets FDA Approval Medical Professionals Reference
The FDA’s latest Untitled Letter chides Novartis for Fabhalta ad - Medical Marketing and Media
The FDA’s latest Untitled Letter chides Novartis for Fabhalta ad Medical Marketing and Media
FDA Authorizes First Eyeglass Lenses to Slow Progression of Childhood Nearsightedness - Dailyfly ...
FDA Authorizes First Eyeglass Lenses to Slow Progression of Childhood Nearsightedness Dailyfly News
Enhertu + Pertuzumab in 1L HER2+ MBC: FDA Priority Review - Oncodaily
Enhertu + Pertuzumab in 1L HER2+ MBC: FDA Priority Review Oncodaily
Complex Innovative Trial Design Meeting Program - fda.gov
Update on Alert: Defibrillation Lead Issue from Boston Scientific - fda.gov
Update on Alert: Defibrillation Lead Issue from Boston Scientific fda.gov
Kennedy says FDA is reviewing safety of mifepristone abortion pill - CBS News
Kennedy says FDA is reviewing safety of mifepristone abortion pill CBS News
What Does the FDA’s Actions Linking Tylenol to Autism Mean? - FindLaw
What Does the FDA’s Actions Linking Tylenol to Autism Mean? FindLaw
FDA Approves Crinetics Pharma's First Daily Pill For Rare Growth Disorder - Yahoo Finance
FDA Approves Crinetics Pharma's First Daily Pill For Rare Growth Disorder Yahoo Finance
Biolinq gets FDA de novo nod for intradermal glucose sensor - MedTech Dive
Biolinq gets FDA de novo nod for intradermal glucose sensor MedTech Dive
FDA Grants Orphan Drug Designation to Utidelone in Pancreatic Cancer - Cure Today
FDA Grants Orphan Drug Designation to Utidelone in Pancreatic Cancer Cure Today
FluidAI Medical’s Origin™ device has received FDA 510(k) clearance, a pivotal milestone redefinin...
FluidAI Medical’s Origin™ device has received FDA 510(k) clearance, a pivotal milestone redefining the future of data-driven, post-operative care Ortho Spine News
Dan Rodricks: Fact-checking FDA commish on Tylenol & autism claims - Baltimore Fishbowl
Dan Rodricks: Fact-checking FDA commish on Tylenol & autism claims Baltimore Fishbowl
FDA Chief Marty Makary on Tylenol, Autism, and Restoring Trust in Science - thefp.com
FDA Chief Marty Makary on Tylenol, Autism, and Restoring Trust in Science thefp.com
Report on the State of Pharmaceutical Quality - fda.gov
Omaha doctor weighs in on Trump administration's claims linking Tylenol use in pregnancy to autis...
Omaha doctor weighs in on Trump administration's claims linking Tylenol use in pregnancy to autism KMTV 3 News Now
RFK Jr. launches FDA safety review of abortion pill mifepristone - LiveNOW from FOX
RFK Jr. launches FDA safety review of abortion pill mifepristone LiveNOW from FOX
Hims & Hers: Growth Meets FDA Scrutiny And Tariff Risks (NYSE:HIMS) - Seeking Alpha
Hims & Hers: Growth Meets FDA Scrutiny And Tariff Risks (NYSE:HIMS) Seeking Alpha
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People - fda.gov
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People fda.gov
Criminal Investigations - fda.gov
Criminal Investigations fda.gov
FluidAI Medical Secures FDA Clearance for AI-Powered Postoperative Monitoring Device - WebProNews
FluidAI Medical Secures FDA Clearance for AI-Powered Postoperative Monitoring Device WebProNews
Rankin County teen wins battle for treatment with FDA drug approval - WLOX
Rankin County teen wins battle for treatment with FDA drug approval WLOX
Infant Formula Guidance Documents & Regulatory Information - fda.gov
Infant Formula Guidance Documents & Regulatory Information fda.gov
FDA Removes REMS Program for Thyroid Cancer Drug Vandetanib - Medscape
FDA Removes REMS Program for Thyroid Cancer Drug Vandetanib Medscape
Scientific Evidence for Cell Phone Safety - fda.gov
Drop off unwanted or unused medicines at a drug take-back location - fda.gov
Drop off unwanted or unused medicines at a drug take-back location fda.gov
Crinetics: FDA Approval And Expansion Of Palsonify In Focus, Maintaining 'Buy' Rating - Seeking A...
Crinetics: FDA Approval And Expansion Of Palsonify In Focus, Maintaining 'Buy' Rating Seeking Alpha
Capricor readies revised FDA pitch for Duchenne cell therapy - BioPharma Dive
Capricor readies revised FDA pitch for Duchenne cell therapy BioPharma Dive
FDA Public Meeting: Onshoring Manufacturing of Drugs and Biological Products - fda.gov
FDA Public Meeting: Onshoring Manufacturing of Drugs and Biological Products fda.gov
Southwind Foods, LLC Recalls Frozen Shrimp Because of Possible Health Risk - fda.gov
Southwind Foods, LLC Recalls Frozen Shrimp Because of Possible Health Risk fda.gov
Get Assistance from the FDA Human Foods Program (HFP) - fda.gov
Get Assistance from the FDA Human Foods Program (HFP) fda.gov
Implementing Alternative Methods - fda.gov
Implementing Alternative Methods fda.gov
FDA warns consumers not to purchase or use any tianeptine product due to serious risks - fda.gov
FDA warns consumers not to purchase or use any tianeptine product due to serious risks fda.gov
Lilly’s oral SERD gets FDA nod in advanced breast cancer - BioPharma Dive
Lilly’s oral SERD gets FDA nod in advanced breast cancer BioPharma Dive
FluidAI Medical's Origin™ device has received FDA 510(k) clearance, a pivotal milestone redefinin...
Chetak LLC Group Recalls Product Because of Possible Health Risk - fda.gov
Chetak LLC Group Recalls Product Because of Possible Health Risk fda.gov
Tianeptine is not approved by the FDA for any medical use - fda.gov
Tianeptine is not approved by the FDA for any medical use fda.gov
Safety Alert - fda.gov
Safety Alert fda.gov
Crinetics drug to challenge pharma ‘Goliaths’; FDA, ARPA move to speed gene therapies - BioPharma...
Crinetics drug to challenge pharma ‘Goliaths’; FDA, ARPA move to speed gene therapies BioPharma Dive
US FDA Review Teams Face ‘Herculean’ Shift to Two-Month Timelines With New Voucher - insights.cit...
US FDA Review Teams Face ‘Herculean’ Shift to Two-Month Timelines With New Voucher insights.citeline.com
FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain ...
FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain fda.gov
Front-of-Package Nutrition Labeling - fda.gov